An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Overview
This bill aims to increase transparency in pharmaceutical drug pricing and prevent what is considered ‘price gouging.’ It seeks to require manufacturers to disclose the factors that contribute to drug price increases and establish a process for reviewing and potentially regulating excessive price hikes. The legislation also intends to ensure that consumers have access to information about the cost of medications.
Key provisions
- Requires pharmaceutical manufacturers to report the factors influencing drug prices.
- Establishes a process for reviewing and potentially regulating excessive price increases.
- Promotes transparency in drug pricing for consumers.
- Addresses concerns about pharmaceutical price gouging.
Who is affected
- Pharmaceutical manufacturers
- Consumers
- Healthcare providers
- The State of Massachusetts
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
2 on record
Primary sponsor
Cosponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours